Bamlanivimab plus etesevimab reduces the likelihood of hospitalization or death in high-risk outpatients with COVID-19 (NNT = 20)

Bamlanivimab plus etesevimab reduces the likelihood of hospitalization or death in high-risk outpatients with COVID-19 (NNT = 20) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

There's more to see -- the rest of this topic is available only to subscribers.